SE7415416L - - Google Patents

Info

Publication number
SE7415416L
SE7415416L SE7415416A SE7415416A SE7415416L SE 7415416 L SE7415416 L SE 7415416L SE 7415416 A SE7415416 A SE 7415416A SE 7415416 A SE7415416 A SE 7415416A SE 7415416 L SE7415416 L SE 7415416L
Authority
SE
Sweden
Prior art keywords
compound
give
reaction
feb
dec
Prior art date
Application number
SE7415416A
Other versions
SE422798B (en
Inventor
P Pfeffli
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH1768973A external-priority patent/CH588488A5/en
Priority claimed from CH162174A external-priority patent/CH596207A5/en
Priority claimed from CH176574A external-priority patent/CH593283A5/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE7415416L publication Critical patent/SE7415416L/xx
Publication of SE422798B publication Critical patent/SE422798B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16Tryptamines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D461/00Heterocyclic compounds containing indolo [3,2,1-d,e] pyrido [3,2,1,j] [1,5]-naphthyridine ring systems, e.g. vincamine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

1492579 Vincamine derivatives SANDOZ Ltd 16 Dec 1974 [18 Dec 1973 6 Feb 1974 8 Feb 1974] 54159/74 Heading C2C Novel compounds I (in which R 1 is Br, F, Cl, OH, or 1-40 alkyl or alkoxy with the proviso that when R 1 is in the 11- or 12-position it is other than -OCH 3 ) are prepared (a) by cyclization of a compound II (in which R 2 is 1-4C alkyl) in the presence of acid; (b) by reaction of a compound III at less than 0‹ C. with a hydrogen halide, followed by hydrolysis or (c) by bromination of vincamine to give the 11-bromo derivative. Compounds II are prepared by reaction of a compound IV with a compound V to give a compound VI reaction of the compound VI with imidazole to give a compound VII treatment of the compound VII with acid to give a compound VIII reaction of the compound VIII with a compound IX to give a compound X Bischler-Napieralski ring closure of the compound X to give a compound XI and reduction of the compound XI. Pharmaceutical compositions exhibiting vigilance-increasing and psychostimulation activity comprise a compound I or a pharmaceutically acceptable acid addition salt thereof together with a suitable excipient and are administered orally or parenterally.
SE7415416A 1973-12-18 1974-12-09 ANALOGY PROCEDURE FOR PREPARING VINCAMIN DERIVATIVES SE422798B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH1768973A CH588488A5 (en) 1973-12-18 1973-12-18 Vincamine derivs for treating behaviour disorders - by ring closure of indoloquinolizine deriv
CH162174A CH596207A5 (en) 1974-02-06 1974-02-06 Vincamine derivs for treating behaviour disorders
CH176574A CH593283A5 (en) 1974-02-08 1974-02-08 Vincamine derivs for treating behaviour disorders - by ring closure of indoloquinolizine deriv

Publications (2)

Publication Number Publication Date
SE7415416L true SE7415416L (en) 1975-06-19
SE422798B SE422798B (en) 1982-03-29

Family

ID=27173122

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7415416A SE422798B (en) 1973-12-18 1974-12-09 ANALOGY PROCEDURE FOR PREPARING VINCAMIN DERIVATIVES

Country Status (16)

Country Link
JP (1) JPS5817474B2 (en)
CA (1) CA1051899A (en)
DD (1) DD116043A5 (en)
DE (1) DE2458164A1 (en)
DK (1) DK139358B (en)
ES (3) ES432952A1 (en)
FI (1) FI59096C (en)
FR (1) FR2254342B1 (en)
GB (1) GB1492579A (en)
HK (1) HK53980A (en)
IE (1) IE40791B1 (en)
MY (1) MY8100186A (en)
NL (1) NL7416237A (en)
NO (1) NO744456L (en)
PH (1) PH12927A (en)
SE (1) SE422798B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2396759A1 (en) * 1977-07-06 1979-02-02 Omnium Chimique Sa Vincamine analogues - for treating cardiovascular, cerebrovascular and respiratory insufficiency
HU177498B (en) * 1977-07-27 1981-10-28 Richter Gedeon Vegyeszet Process for preparing new vincinic acid and apovincinic acid esters
FR2423493A1 (en) * 1977-10-19 1979-11-16 Omnium Chimique Sa Vincamine analogues - for treating cardiovascular, cerebrovascular and respiratory insufficiency
FR2407931A1 (en) * 1977-11-02 1979-06-01 Synthelabo DERIVATIVES OF EBURNAMENINE AND THEIR APPLICATION IN THERAPEUTICS
JPS5493000A (en) * 1977-12-28 1979-07-23 Sandoz Ag Improvement of organic compound
DE2800063A1 (en) * 1978-01-02 1979-07-12 Sandoz Ag Vigilance increasing and psycho-stimulant 10-bromo-vincamine - prepd. e.g. by redn. and rearrangement of 15-bromo-1,2-di:dehydro-3-hydroxy-aspidospermidine-3-carboxylic acid methyl ester
FR2445328A1 (en) * 1978-07-12 1980-07-25 Richter Gedeon Vegyeszet DERIVATIVES OF 14-OXO-E-HOMO-EBURNANE, THEIR PREPARATION PROCESS AND THEIR USE AS MEDICAMENT
US4315011A (en) * 1978-07-12 1982-02-09 Richter Gedeon Vegyeszeti Gyar Rt. 1-Alkyl-9-bromohexahydroindolo quinolizium salts and use thereof to increase blood flow
US4285949A (en) * 1978-12-11 1981-08-25 Omnichem Societe Anonyme Vincamine derivatives, their preparation and therapeutical use
HU177732B (en) * 1978-12-15 1981-12-28 Richter Gedeon Vegyeszet Process for producing 10-bromo-vincamine and acid additional salts thereof,and 10-bromo-14-epivincamine
HU180928B (en) * 1979-08-06 1983-05-30 Richter Gedeon Vegyeszet Process for preparing new brominated 15-hydroxy-e-homo-eburane derivatives
HU180929B (en) * 1979-08-13 1983-05-30 Richter Gedeon Vegyeszet Process for producing new bromo-vincamone derivatives
HU185305B (en) * 1981-08-23 1985-01-28 Richter Gedeon Vegyeszet Process for preparing vincine and apovincine
HU183326B (en) * 1981-02-11 1984-04-28 Richter Gedeon Vegyeszet Process for preparing new apovincaminol-3',4',5'-trimethoxy-benzoates substituted in the a ring and acid addition salts thereof
ES8604952A1 (en) * 1985-11-05 1986-03-16 Covex Sa Production of methyl 10/11-bromo-14, 15-dihydro-14-beta-hydroxy-(3 alpha, 16 alpha)- eburunamenine-carboxylate compound
US4883876A (en) * 1987-09-07 1989-11-28 Taisho Pharmaceutical Co., Ltd. Acylated vincaminic acid derivatives

Also Published As

Publication number Publication date
FI355274A (en) 1975-06-19
SE422798B (en) 1982-03-29
NL7416237A (en) 1975-06-20
MY8100186A (en) 1981-12-31
FR2254342B1 (en) 1978-07-21
JPS50105700A (en) 1975-08-20
ES450740A1 (en) 1977-12-16
DK139358C (en) 1979-07-09
HK53980A (en) 1980-10-03
FI59096C (en) 1981-06-10
CA1051899A (en) 1979-04-03
DD116043A5 (en) 1975-11-05
ES450741A1 (en) 1978-03-16
PH12927A (en) 1979-10-10
DK139358B (en) 1979-02-05
JPS5817474B2 (en) 1983-04-07
GB1492579A (en) 1977-11-23
IE40791L (en) 1975-06-18
NO744456L (en) 1975-07-14
ES432952A1 (en) 1977-02-16
DE2458164A1 (en) 1975-06-26
IE40791B1 (en) 1979-08-15
AU7648374A (en) 1976-06-17
FI59096B (en) 1981-02-27
DE2458164C2 (en) 1991-04-18
FR2254342A1 (en) 1975-07-11
DK639774A (en) 1975-08-25

Similar Documents

Publication Publication Date Title
SE7415416L (en)
GB1422295A (en) Indole derivatives
GB1360219A (en) 4h-benzo-4,5 - cyclohepta-1,2 - b-thiophen-9-ones and process for their manufacture
GB1228739A (en)
GB1417542A (en) Theophylline 7acetate salts
GB1496491A (en) Dihydroergopeptine derivatives
GB1174349A (en) Novel 2-Anilinomethylimidazoline Derivatives and process for the preparation thereof
GB1352245A (en) Azabicyclo-3.3.1-nonan-3-ol ester derivatives
ES427115A1 (en) Novel benzoylphenylacetic acid derivatives
GB1438260A (en) Sulphoxides and sulphones processes for their preparation and compositions containing them
GB1276968A (en) Improvements in or relating to phenylacetamides and the preparation thereof
GB1235957A (en) Alkaloid derivative
GB1298619A (en) Thieno benzopyran and thiopyrano benzopyran derivatives and method of making the same
GB1173809A (en) N-Substituted Nor-Morphines
GB1153666A (en) N-Alkylazaindoles
GB1409828A (en) Pharmaceuticals and process for their preparation
GB1428868A (en) Spa 8- alpha-nicotinolyxyethyl-caffeine derivatives
GB1430912A (en) 8-beta-hydroxyethyl-ergoline derivatives
GB1332635A (en) Rutin complexes
GB1179051A (en) Phenethylamino-Propan-2-ones and -Propan-2-Ols
GB1355689A (en) Piperidylfuranones
IE34268L (en) Hydrazines and hydrazones of pyrazolopyridine carboxylic¹acids and esters.
GB1317848A (en) N-thienylalkyl-beta-alkoxy-trifluoromethylphenalkylamines
GB1457950A (en) Antibacterial compositions
GB1144060A (en) Novel phthalimidine derivatives and a process for the manufacture and conversion thereof

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7415416-2

Effective date: 19920704

Format of ref document f/p: F